• For Institutions

    • Corporate Services
    • Developers
  • Download
  • Help
  • About

    • Company Profile
    • License & Regulatory
    • Media coverage
longbridgelongbridge
longbridgelongbridge
Products
Pricing
Markets
Global Markets
Stock Screener
Information
Insights
News
Live
Academy
Affiliate Program
Promotions
PortAI
EN
English
简体中文
繁體中文
繁體中文(廣東話)Posts & comments will be shown in Cantonese
Search...
Quote ListQuote List
Overview
News
Financials
© 2025 Longbridge|Disclaimer

Event Tracking

Jul24
Eli Lilly's Acquisition of Verve Set to Complete
12:13
Jul15
Verve Therapeutics Launches Retention Bonus Plan for Executives
10:46
Jun28
BMO downgrades Verve Therapeutics
12:05
Jun18
FactSet analysts rate Verve Therapeutics as outperform with average target price
11:17
Jun17
Canadian Investment Bank Downgrades Verve Therapeutics' Rating and Target Price
15:04
Jun10
Verve Therapeutics Holds Annual Shareholders Meeting to Elect Directors
20:17

Schedules & Filings

Schedules
Filings
May14
Earning Release(EST)

FY2025 Q1 Earning Release (USD) Revenue 32.98 M, Net Income -31.03 M, EPS -0.3494

Feb27
Earning Release(EST)

FY2024 Q4 Earning Release (USD) Revenue 13.08 M, Net Income -50.04 M, EPS -0.5759

Nov5
Earning Release(EST)

FY2024 Q3 Earning Release (USD) Revenue 6.865 M, Net Income -50.13 M, EPS -0.5923

View More

Stock List

Top Gainers
Top Decliners
China Concepts
Symbol
Price
%Chg
Change
FJET
8.500
+136.77%
+4.910
AFJK
52.230
+100.81%
+26.220
DJTU
5.160
+83.63%
+2.350
ATHA
6.720
+62.52%
+2.585
SOC
8.250
+56.25%
+2.970
ZNB
1.020
+55.73%
+0.365
VIVK
0.0751
+47.25%
+0.024
SGD
0.2518
+42.26%
+0.075
DJT
14.860
+41.93%
+4.390
VSME
0.1035
+38.37%
+0.029
View More